Oral formulation for dexlansoprazole
- 专利权人:
- Handa Pharmaceuticals; LLC
- 发明人:
- Shen, Zhiqun,Zhang, Yu,Fu, Enjun,He, Min Michael,Liu, Fang-Yu
- 申请号：
- AU2010321874
- 公开号：
- AU2010321874A1
- 申请日:
- 2010.11.18
- 申请国别(地区):
- AU
- 年份:
- 2012
- 代理人:
- 摘要：
- A stable formulation of dexlansoprazole for treating a digestive disorder, and methods of manufacturing the same.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ORAL FORMULATION FOR DEXLANSOPRAZOLE
- Use of an angiotensin ii receptor antagonist for the production of a pharmaceutical composition for the prevention or treatment of vascular diseases or metabolic disorders and / or systemic disease in cats.
- COMPOSITION WITH GROWTH FACTORS, TO BE USED IN THE INTRANASAL TREATMENT OF A NEURODEGENERATIVE DISEASE OR OTHER DISEASES OF THE CENTRAL NERVOUS SYSTEM, AND ITS METHOD OF MANUFACTURE
- COMPOSITION WITH GROWTH FACTORS, TO BE USED IN THE INTRANASAL TREATMENT OF A NEURODEGENERATIVE DISEASE OR OTHER DISEASES OF THE CENTRAL NERVOUS SYSTEM, AND ITS METHOD OF MANUFACTURE
- 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
